XML 20 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Long-term Debt and Other Financing Arrangements
3 Months Ended
Mar. 31, 2015
Debt Disclosure [Abstract]  
Long-term Debt and Other Financing Arrangements
Long-term Debt and Other Financing Arrangements
 
The Company's long-term borrowing consisted of the following (in thousands, except for interest rates):
 
Description
 
Interest
rate
 
March 31,
2015
 
December 31, 2014
Senior secured debt – HSBC Bank PLC
 
1.10
%
 
$
2,977

 
$

Promissory note—Payable to Former Shareholder of TLC
 
2.63
%
 
3,281

 
3,373

Promissory note—Lega Enterprises, LLC (formerly Agel Enterprises, LLC)
 
5.00
%
 
1,261

 
1,367

Other miscellaneous notes
 
4.00
%
 
467

 
516

Total debt
 
 

 
7,986

 
5,256

Less current maturities
 
 

 
(905
)
 
(940
)
Long-term debt
 
 

 
$
7,081

 
$
4,316



Senior Secured debt – HSBC Bank PLC
 
On March 24, 2015, the Company secured $3.0 million in senior secured debt from HSBC Bank PLC, with a term of two years and an annual interest rate of 0.60% over the Bank of England Base Rate as published from time to time.
 
Promissory Note—Payable to Former Shareholder of TLC
 
On March 14, 2013, we issued a $4.0 million promissory note in connection with the purchase of TLC. The Promissory Note bears interest at 2.63% per annum, has a ten-year maturity, and is payable in equal monthly installments of outstanding principal and interest.
 
Promissory Note—Lega Enterprises, LLC
 
On October 22, 2013, we issued a $1.7 million promissory note to Lega Enterprises, LLC (formerly Agel Enterprises, LLC) in connection with AEI's acquisition of assets from Agel Enterprises LLC. The promissory note bears interest at 5% per annum, and is payable in equal monthly installments of outstanding principal and interest and matures on October 22, 2018.
 
Promissory Note – Other Miscellaneous
 
On December 4, 2014, we issued a $0.5 million promissory note in connection with a settlement agreement. The promissory note bears interest at 4% per annum, and is payable in equal monthly installments of outstanding principal and interest.
 
Capital Lease
 
On July 31, 2014, TLC entered into the Sale Leaseback Agreement with CFI. The lease was deemed to qualify as a capital lease and the transaction is being accounted for as a sales leaseback arrangement. The gain arising from the sale of the three buildings and related property was deferred and is being recognized using the full accrual method over the term of the lease. The lease has been classified as a capital lease since the condition was met whereby the term of the lease is greater than 75% of the estimated economic life of the property. TLC has recorded the sale and removed the properties sold and related liabilities from the balance sheet. Since the lease is a capital lease, a leased asset will be recorded and depreciated over 15 years using the straight-line method.
 
The payment under the lease will be accounted for as interest and payments under capital lease using 15 year amortization. Interest expense of $552,000 associated with the lease payments was recognized in the three months ended March 31, 2015. Depreciation expense of $263,000 was recorded in the three months ended March 31, 2015, of which $141,000 was included in cost of goods sold. The gain on sales of real estate was $42,000, which represents three months of the gain amortized over the life of the lease.

Outstanding Warrants
 
On March 4, 2015 the Company raised proceeds of $20 million though the sale of 6,667,000 shares of its common stock and warrants to purchase up to an aggregate of 6,667,000 shares of its common stock at a combined offering price of $3.00 in an underwritten public offering (“Offering”). The warrants have a per share exercise price of $3.75, are exercisable immediately and will expire five years from the date of issuance. The Company granted the underwriters a 45-day option to purchase up to an additional 1,000,050 shares of common stock and/or warrants to purchase up to an aggregate of 1,000,050 shares of common stock to cover additional over-allotments, if any. On March 4, 2015, the underwriters exercised a portion of their over-allotment option with respect to 113,200 warrants. In addition, 166,675 warrants were issued to the underwriters. The over-allotment option has expired as of the date of this filing.

The gross proceeds to the Company, including the underwriters' partial exercise of their over-allotment option, were approximately $20,000,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Assuming the exercise of all 6,667,000 warrants at the exercise price of $3.75 each, and assuming the Company maintains the conditions necessary for a cash exercise, the total additional gross aggregate proceeds to JRjr would be $25,001,250. However, there can be no assurance that any warrants will be exercised.

On May 6, 2014, the Company issued warrants to purchase up to 12,500 and 6,250 shares of its Common Stock in connection with exclusivity agreements. The warrants were exercisable commencing 75 days after their date of issuance, in whole or in part, until one year from the date of issuance for cash and/or on a cashless exercise basis at an exercise price of $11.00 per share, representing the average closing price of our common stock for the ten days preceding the issuance. In addition, the warrants provide for piggyback registration rights upon request, in certain cases. The exercise price and number of shares issuable upon exercise of the warrants is subject to adjustment in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation,. The fair value of the warrants on the date of issuance approximated $116,000.
 
On July 2, 2014, the Company issued a warrant exercisable for 50,000 shares of our common stock at an exercise price of $12.80 per share in consideration of a two-year consulting agreement with an individual with direct selling industry experience. The warrant is exercisable for a five day period commencing 720 days after issuance, however, the warrant expires without an opportunity to exercise it on July 1, 2015, unless the term is extended for an additional year if on July 1, 2015 the shares of common stock underlying the warrant are subject to an effective registration statement under the Securities Act of 1933, as amended (the "Securities Act") or our common stock is listed on the Nasdaq National Market or the NYSE MKT. In addition, the warrant provides for piggyback registration rights upon request, in certain cases. The exercise price and number of shares issuable upon exercise of the warrants is subject to adjustment in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation.